Stocktoria
USANA HEALTH SCIENCES INC USNA
NYSE · XNYS · stock · Medicinal Chemicals & Botanical Products · website · IPO 1993-10-28
USANA HEALTH SCIENCES INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 78.3% | 81.1% | 80.8% | 80.6% | 81.6% |
| Operating margin | 4.0% | 7.8% | 10.1% | 10.8% | 14.3% |
| Net margin | 1.2% | 4.9% | 6.9% | 6.9% | 9.8% |
| FCF margin | 0.9% | 6.0% | 6.1% | 9.4% | 9.1% |
| Return on assets | 1.4% | 5.6% | 10.1% | 11.6% | 20.2% |
| Return on equity | 2.0% | 7.9% | 12.8% | 16.0% | 29.5% |
| Current ratio | 2.24 | 2.00 | 3.52 | 2.67 | 2.27 |
| Revenue growth | 8.3% | -7.2% | -7.8% | -15.8% | 4.6% |
Source: SEC EDGAR filings · CIK 0000896264 · as of 2026-01-03. Facts from filings plus Stocktoria's own computed scores — not investment advice.